This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwarz, F. Articles by Kubler, W. Search for Related Content PubMed PubMed Citation Articles by Schwarz, F. Articles by Kubler, W.

Circulation, Vol 70, 923-928, Copyright © 1984 by American Heart Association

ARTICLES

Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics

F Schwarz, G Mall, H Zebe, E Schmitzer, J Manthey, H Scheurlen and W Kubler

We analyzed data from 68 consecutive patients with congestive cardiomyopathy to evaluate the prognostic significance of quantitative morphologic findings in left ventricular myocardium as compared with the prognostic significance of left ventricular hemodynamics. Left ventricular endomyocardial biopsy specimens were obtained from all patients during diagnostic heart catheterization. Myocardial fiber diameter, volume fraction of interstitial fibrosis, and intracellular volume fraction of myofibrils were determined by light-microscopic morphometry. All patients had normal coronary arteriograms, but reduced left ventricular ejection fractions. There were 23 deaths during a mean follow-up period of 1124 days. Multivariate regression analysis (Cox model) revealed that left ventricular ejection fraction (p less than .00001) and left ventricular systolic pressure (p less than .01), but not morphometric findings in biopsy specimens, were independent predictors of cardiac death. Thus, morphologic findings in the left ventricular myocardium do not contribute significantly to the prognostic evaluation in patients with congestive cardiomyopathy studied by hemodynamic and angiographic methods.

This article has been cited by other articles:

				A. Vlahovic Stipac, P. Otasevic, Z. B. Popovic, V. Cvorovic, B. Putnikovic, I. Stankovic, and A. N. Neskovic Prognostic significance of contractile reserve assessed by dobutamine-induced changes of Tei index in patients with idiopathic dilated cardiomyopathy Eur J Echocardiogr, December 7, 2009; (2009) jep208v1. [Abstract] [Full Text] [PDF]

				T. Tsukamoto, K. Morita, M. Naya, M. Inubushi, C. Katoh, K. Nishijima, Y. Kuge, H. Okamoto, H. Tsutsui, and N. Tamaki Decreased Myocardial {beta}-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy J. Nucl. Med., November 1, 2007; 48(11): 1777 - 1782. [Abstract] [Full Text] [PDF]

				S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, S. Tange, T. Suzuki, and M. Kurabayashi Dobutamine Stress 99mTc-Tetrofosmin Quantitative Gated SPECT Predicts Improvement of Cardiac Function After Carvedilol Treatment in Patients with Dilated Cardiomyopathy J. Nucl. Med., November 1, 2004; 45(11): 1878 - 1884. [Abstract] [Full Text] [PDF]

				K. Fukuchi, Y. Yasumura, K. Kiso, K. Hayashida, K. Miyatake, and Y. Ishida Gated Myocardial SPECT to Predict Response to {beta}-Blocker Therapy in Patients with Idiopathic Dilated Cardiomyopathy J. Nucl. Med., April 1, 2004; 45(4): 527 - 531. [Abstract] [Full Text] [PDF]

				T. Z. Naqvi, R. K. Goel, J. S. Forrester, and R. J. Siegel Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1537 - 1544. [Abstract] [Full Text] [PDF]

				Y Yazaki, M Isobe, W Takahashi, H Kitabayashi, O Nishiyama, M Sekiguchi, and T Takemura Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course Heart, February 1, 1999; 81(2): 153 - 159. [Abstract] [Full Text]

				D. B. Chomsky, C. C. Lang, G. H. Rayos, Y. Shyr, T.-K. Yeoh, R. N. Pierson III, S. F. Davis, and J. R. Wilson Hemodynamic Exercise Testing: A Valuable Tool in the Selection of Cardiac Transplantation Candidates Circulation, December 15, 1996; 94(12): 3176 - 3183. [Abstract] [Full Text]

				M. R. Costanzo, S. Augustine, R. Bourge, M. Bristow, J. B. O'Connell, D. Driscoll, and E. Rose Selection and Treatment of Candidates for Heart Transplantation : A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association Circulation, December 15, 1995; 92(12): 3593 - 3612. [Abstract] [Full Text]

				R. Zimmermann, G. Mall, B. Rauch, G. Zimmer, M. Gabel, J. Zehelein, B. Bubeck, H. Tillmanns, S. Hagl, and W. Kubler Residual 201Tl Activity in Irreversible Defects as a Marker of Myocardial Viability : Clinicopathological Study Circulation, February 15, 1995; 91(4): 1016 - 1021. [Abstract] [Full Text]

				P. R. Marantz, J. N. Tobin, S. Wassertheil-Smoller, C. Ahn, R. M. Steingart, and J. P. Wexler Prognosis in Ischemic Heart Disease: Can You Tell as Much at the Bedside as in the Nuclear Laboratory? Arch Intern Med, December 1, 1992; 152(12): 2433 - 2437. [Abstract] [PDF]

				D. D. Sugrue, R. J. Rodeheffer, M. B. Codd, D. J. Ballard, V. Fuster, and B. J. Gersh The Clinical Course of Idiopathic Dilated Cardiomyopathy: A Population-based Study Ann Intern Med, July 15, 1992; 117(2): 117 - 123. [Abstract] [PDF]

				T. J. Regan Alcohol and the Cardiovascular System JAMA, July 18, 1990; 264(3): 377 - 381. [Abstract] [PDF]

				D. Bansch, M. Antz, S. Boczor, M. Volkmer, J. Tebbenjohanns, K. Seidl, M. Block, F. Gietzen, J. Berger, and K. H. Kuck Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT) Circulation, March 26, 2002; 105(12): 1453 - 1458. [Abstract] [Full Text] [PDF]